Cargando…
Clinical Performance of Cobas 6800 for the Detection of High-Risk Human Papillomavirus in Urine Samples
Testing for high-risk human papillomavirus (HPV) as part of primary cervical cancer screening has become more common recently. The Cobas 6800, an FDA-approved cervical screening platform, detects 14 high-risk HPVs, including HPV16 and HPV18. However, this test is limited to only women, which leads t...
Autores principales: | Hajjar, Brian Joseph, Raheel, Ummar, Manina, Rachel, Simpson, Jovanie, Irfan, Muhammad, Waheed, Yasir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305403/ https://www.ncbi.nlm.nih.gov/pubmed/37376460 http://dx.doi.org/10.3390/vaccines11061071 |
Ejemplares similares
-
Evaluating the Efficiency of the Cobas 6800 System for BK Virus Detection in Plasma and Urine Samples
por: Song, Junhyup, et al.
Publicado: (2023) -
Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021) -
Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019) -
Trichomonas vaginalis Detection in Female Specimens with cobas(®) TV/MG for use on the cobas(®) 6800/8800 Systems
por: Marlowe, Elizabeth M., et al.
Publicado: (2019) -
Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples
por: Van Der Pol, Barbara, et al.
Publicado: (2019)